INTRODUCTION. Objectives. When the student has finished this module, he/she will be able to:

Similar documents
INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to:

Hydrofluoric Acid Toxicity Author: Z. Kazzi / E. A. Numur / S. Kini. Target Audience: Emergency Medicine Residents

In the US: More than 1000 cases of HF exposure are reported annually. Actual incidence rate is unknown.

Hydrofluoric acid (HF) C 1

Standard Operating Procedure (SOP)

Hypocalcemia 6/8/12. Normal value. Physiologic functions. Nephron a functional unit of kidney. Influencing factors in Calcium and Phosphate Balance

PACKAGE INSERT CALCIUM GLUCONATE INJECTION, USP 10% Electrolyte Replenisher mosmol/ml 680 mosmol/l Ca meq/ml ph

Limited Efficacy of Calcium and Magnesium in a Porcine Model of Hydrofluoric Acid Ingestion

HOW TO HANDLE BASIC MEDICAL EMERGENCIES

Clinical Research Coordinator Skills Program

Chapter 16 Nutrition, Fluids and Electrolytes, and Acid-Base Balance Nutrition Nutrients Water o Functions Promotes metabolic processes Transporter

Management of patients with thyroid cancer scheduled for thyroidectomy at RCHSD

CUSTODIAL RISKS THE INVISIBLE PROBLEM. Ed Jackson

SODIUM POLYSTYRENE SULFONATE Suspension, USP

5/18/2017. Specific Electrolytes. Sodium. Sodium. Sodium. Sodium. Sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate

Honeywell Hydrofluoric Acid. Recommended Medical Treatment for Hydrofluoric Acid Exposure

When the learner has completed this module, she/he will be able to:

Chemical Safety for SRF Work Introduction

PRODUCT INFORMATION RESONIUM A. Na m

Comparative Efficacy of Injectable Calcium and Magnesium Salts in the Therapy of Hydrofluoric Acid Burns

NORMOSOL -R MULTIPLE ELECTROLYTES INJECTION TYPE 1, USP For Replacing Acute Losses of Extracellular Fluid Flexible Plastic Container

Lina AL-Lawama and Tasneem Montaj. Abdullah Nimer. Loai Zghoul

WHY HYDROFLUORIC ACID?

Industrial Fluorines. Recommended Medical Treatment for Hydrofluoric Acid Exposure

ISPUB.COM. Electrolyte Replacement: A Review. B Phillips INTRODUCTION ELECTROLYTES I. CALCIUM

Investigations for Disorders of Calcium, Phosphate and Magnesium Homeostasis

GPS* Safety Summary for Sodium Hydroxide

Measuring body temperature, blood pressure, pulse, respiratory rate and oxygen saturation

User Manual Table of Contents. Instructions for Using the LaserTouchOne Charging the Unit... 5 Holding the Device... 5 Treatment Steps...

Safety Data Sheet 1. PRODUCT AND COMPANY IDENTIFICATION 2. HAZARDS IDENTIFICATION. Product Name: Vari-Etch Frosting Powder. SDS Date: 06/01/2015

Hydrofluoric Acid Exposure A Double Whammy That s Not Just Skin Deep

Safety Data Sheet 1. PRODUCT AND COMPANY IDENTIFICATION 2. HAZARDS IDENTIFICATION. Product Name: Vari-Etch Frosting Cream. MSDS Date: 06/01/15

5 th Annual Conference of the Periodic Paralysis Association. October 24-25, 2003

User Manual.

DBL MAGNESIUM SULFATE CONCENTRATED INJECTION

RNZ INTERNATIONAL FZE MSDS. SECTION 1. Product And Company Identification. Company Name: RNZ INTERNATIONAL FZE

3M Tegaderm CHG Chlorhexidine Gluconate I.V. Securement Dressing Description 3M Tegaderm CHG Chlorhexidine Gluconate I.V. Securement Dressing is used

Chapter 153 Caustics. Episode Overview: Wisecracks. Key Points: Rosen s in Perspective

Sexual Concerns. Mental Health Topics

Ears. Mouth. Jowls 6 Major Bones of the Face Nasal bone Two

Pitfalls in chemical burns

PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING

Instrumental determination of electrolytes in urine. Amal Alamri

Major intra and extracellular ions Lec: 1

Magnesium Sulphate - Management of Hypertensive Disorders of Pregnancy

Liquid Consumption, Your Health, And Hyponatremia

Drug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe)

Temperature Extremes

Cancer and the Risk of Blood Clots

Taking and recording blood pressure and pulse. City Gate Training Centre all rights reserved

Patient Resources: Cardiac Channelopathies

Dri-Sate DC, DR and DF Series Dry Acid Concentrate for Hemodialysis 45X, 36.83X and 35X Dilution

Pandemic Influenza Infection Control Measures

Calcium (Ca 2+ ) mg/dl

GOING IN THE INJECTING THE

Module Summaries: The emergency plan is a crucial part of the total sports program.

10/1/2012. Recognizing Causes, Minimizing Risk Susan Clouser RN MSN CRNO. Independent TASS/Endophthalmitis Consultant (Eye Consult LLC) Alcon Contract

Which Diseases Should My Child Be Protected Against?

Surgical Care at the District Hospital. EMERGENCY & ESSENTIAL SURGICAL CARE

Chapter 26 Fluid, Electrolyte, and Acid- Base Balance

Chapter 12 - Vital_Signs_and_Monitoring_Devices

Risk factors and drugs/infusion commonly associated with tissue damage include: Extreme Prematurity Dextrose greater than 12.

Nonparenteral medications

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

Westco Chemicals, Inc Saticoy Street South - North Hollywood, CA TEL: FAX:

Skin Integrity and Wound Care

SAFETY DATA SHEET BWT-27

WATER, SODIUM AND POTASSIUM

A Mnemonic for the Treatment of Hyperkalemia. Nick Wolters, PGY1 Resident Grandview Medical Center

Operation-Fluids-Electrolytes-Acid Base COMPLICATIONS OF DIALYSIS 2

Sodium Bromide, Liquid Sodium Bromide

Chapter 20 8/23/2016. Fluids and Electrolytes. Fluid (Water) Fluid (Water) (Cont.) Functions

WAXAHACHIE INDEPENDENT SCHOOL DISTRICT ATHLETIC GUIDELINES FOR PRACTICING IN HEAT ENVIROMENTS

Table of Contents. Intramuscular Injection Secrets. Page 2 of 9. Nursing School Made Simple Guaranteed 2014 SimpleNursing.com All Rights Reserved.

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE. MEASURING BLOOD PRESSURE - MANUAL (equ04)

SOUTHERN HEALTH & SOCIAL CARE TRUST. Children & Young People s Directorate Procedure/Guidelines/Protocol Checklist & Version Control Sheet

Amjad Bani Hani Ass.Prof. of Cardiac Surgery & Intensive Care FLUIDS AND ELECTROLYTES

This indication includes the temporary relief of burning, irritation, and/or discomfort due to dryness of the eye.

Material Safety Data sheet

Proposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate

Latex and Occupational Dermatitis Policy Incorporating Glove Selection

BODY SYSTEMS, DRUGS, AND OBSERVATIONS SCOPE OF UNIT: This unit includes guidelines for observing and reporting.

Heart catheterization for adults with congenital heart disease

CARPAL TUNNEL RELEASE

YOUR HOME ENTERAL NUTRITION SURVIVAL GUIDE FOR JEJUNOSTOMY FEEDINGS

ZADITEN Eye Drops 1.0%

#6 - Cardiovascular III Heart Sounds, Pulse Rate, Hemoglobin Saturation, and Blood Pressure

CSI (Clinical Scenario Investigation): Hyperkalemia

Understanding & Alleviating Constipation. Living (Well!) with Gastroparesis Program Warm-Up Class

I write in response to your request for information in relation to pharmacy drug guidelines within NHS Lothian.

Advanced Resuscitation - Adult

ARBONNE PHYTOSPORT. Fueled by Nature

50% Concentrated Injection

Duputytren's Contracture

Pain management following your operation

ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments

Normosol -R and 5% Dextrose Injection MULTIPLE ELECTROLYTES AND 5% DEXTROSE INJECTION TYPE 1, USP For Replacing Acute Losses of Extracellular Fluid

Electrolyte Imbalance and Resuscitation. Dr. Mehmet Okumuş Sütçü Imam University Faculty of Medicine Department of Emergency Medicine

Transcription:

Hydrofluoric Acid Burns WWW.RN.ORG Reviewed September 2017, Expires September 2019 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2017 RN.ORG, S.A., RN.ORG, LLC Developed by Dana Bartlett, RN, MSN, CPS INTRODUCTION Few nurses are familiar with the pathophysiology and treatment of hydrofluoric (HF) acid burns and given the unique nature of these injuries, RNs working in ER or ICU need to know what HF acid can do and how to care for a HF acid burn. Unlike other chemical burns, HF acid burns can produce serious systemic effects, small amounts and exposure of a small body surface area (BSA) can be dangerous, and the dermal injury caused by HF acid is often disproportionately mild in appearance compared to the severe pain HF acid can cause and its potential systemic effects. Objectives When the student has finished this module, he/she will be able to: 1. Identify three household products that contain HF acid. 2. Identify the electrolyte abnormalities caused by HF acid. 3. Identify the most common cause of death due to HF acid exposure. 4. Identify a unique feature of HF acid burns. 5. Identify three potentially serious HF acid exposure scenarios. 6. Identify an important concept about the onset of pain caused by HF acid burns. 7. Identify the immediate treatment for a serious HF acid burn. 8. Identify the proper technique for using topical calcium to treat HF acid burns. 9. Identify the proper technique for using intradermal calcium to treat HF acid burns. 10. Identify the proper technique for using intraarterial calcium to treat HF acid burns. HYDROFLUORIC ACID: BASIC FACTS AND PATHOPHYSIOLOGY Hydrofluoric acid is an acid that is in common use in industry, and it is also found in aluminum cleaners, automobile wheel cleaners,

ceramic cleaners, and rust removers that can be purchased for home use. It is a relatively weak acid with a ph of 3.5. Products that can be purchased over-the-counter have low percentage of HF acid, usually 5%-8% or less. Hydrofluoric acid can cause dermal burns, but unless the concentration of the product is > 50%-70%, the burns caused by HF acid are often mild. The burned area may be red, swollen, and occasionally it will be blistered, but it is very likely that it will not look alarming. However, HF acid burns can be very, very painful the pain is often far in excess of what would be expected from the appearance of the burn and HF acid can produce serious, life-threatening systemic toxicity. Burns: As mentioned, the pain caused by many HF acid burns is frequently very disproportionate to the obvious tissue damage. Also, unless the patient has been burned with a strong solution, the onset of the pain is delayed many hours sometimes as long as 24 hours after the exposure. These effects happen for several reasons. First, HF acid is a weak acid and most people are exposed to low concentration solutions. Second, most of the pain from a HF acid burn is not due to the external tissue damage from the chemical burn. Most acids cause a coagulation necrosis. The acid damages tissues by denaturing proteins, but this process produces a thick, tough scar that stops the acid from penetrating further. However, HF acid does not do this. HF has a very high permeability coefficient so it easily penetrates the skin, and when it does, the fluoride ion dissociates from hydrogen. When this happens, the F ions cause direct tissue damage but they also form complexes with calcium, magnesium, and these complexes directly irritate nerves and also cause mechanical damage. Hydrofluoric acid is also thought to poison the Na + -K + ATPase pump and it cause hyperkalemia, and the high serum potassium can irritate nerves and pain sensors. When the HF acid solution is very dilute, the processes of penetration and dissociation are slow and take a long time, so the onset of the pain is delayed. Also, because HF is a weak acid, the process of dissociation and the visible damage caused by the H + ions takes a long time unlike strong aids such as muriatic acid, nitric acid, etc. Learning Break: A HF burn may be unimpressive in appearance because the tissue damage is happening below the surface, but the patient can be having excruciating pain. Because of this and because

the onset of pain is often delayed, these cases can be very deceptive to triage and assess. Systemic Effects: If the solution is very strong, or the duration of contact is long, or the amount of BSA that is burned is high, severe and life-threatening effects are possible. When HF acid penetrates the skin and dissociates, the fluoride ion avidly binds to calcium and magnesium and poisons the Na + -K + ATPase pump. Hypocalcemia, and hypomagnesemia can be profound, and serum potassium can be very elevated. Low serum levels of calcium and magnesium and high serum levels of potassium can seizures, arrhythmias, and death. Ventricular arrhythmias are the primary cause of death from HF acid exposures. SIGNS AND SYMPTOMS OF HYDROFLUORIC ACID BURNS Most HF acid burns are not dramatic in appearance. This is because the majority of these injuries involve dilute solutions of HF acid and because the tissue damage and nerve irritation is happening below the epidermis. Fingers and hands are the areas most often affected because patients neglect to wear gloves when using aluminum cleaners, rust removers, etc. The area is swollen, and the skin is erythematous or white and very painful. High concentrations cause erythema, blisters, and necrosis and in severe cases, bone damage. The onset of pain depends on the HF acid concentration: the weaker the concentration, the longer it takes for the pain to manifest. If the concentration is 0-20%, the onset of pain may be delayed for 24 hours; if the concentration is 20%-50%, the onset of pain may be delayed 1-8 hours; and if the concentration is > 50% pain will happen immediately. As mentioned previously, if the exposure to HF acid was serious, the patient may have signs and symptoms of serious electrolyte disorders. TRIAGE AND ASSESSMENT OF A HYDROFLUORIC ACID EXPOSURE When a patient presents with a HF acid exposure, determine the concentration of the acid, the BSA affected, the location of the burn, the duration of contact, and what decontamination procedures were done. There are three situations of HF acid burns that can be very dangerous. If the patient has been exposed to HF acid in one of the following ways, there is potential for serious complications and death.

Hydrofluoric acid burns to the face: Any HF acid burn to the face caused by any concentration of the product should be considered to be potentially dangerous. BSA burn of > 5% from any concentration of HF acid. BSA burn of 1% of a HF acid concentration 50% Learning Break: Any patient who has been exposed to HF acid in one of these ways should immediately be placed in a monitored bed. These patients cannot wait to be evaluated and treated. Deaths have been reported from HF acid burns involving 2.5% BSA. If the patient does not a potentially dangerous exposure, perform a physical assessment and determine the circumstances of the exposure. Find out when the patient was exposed, what he/she was exposed to, the concentration of the solution, how the exposure occurred, how long the acid had contact with the skin, and what decontamination, if any was performed. Ask the patient where the pain is, when it started, and how much pain he/she is having. Don t forget: The area that was exposed and the burn may not appear badly damaged, but the patient may well be in considerable pain. Examine the exposed area for signs of tissue damage, swelling, redness, tenderness to touch, etc. Determine if the pulse is regular or irregular. Other things to look for are the presence of tetany, the Chvostek sign, or the Trousseau sign. These are all indicators of hypocalcemia. A prolonged QT interval is an early indicator of hypocalcemia and/or hypomagnesemia. Learning Break: The Chvostek sign is a spasm of the facial muscles that is elicited by tapping the facial nerve in the area of the parotid gland (anterior to the ear at the level of the bottom of the ear lobe). The Trousseau sign is defined as spasmodic contraction of muscles when the nerves associated with the muscles are stimulated. The Trousseau sign is elicited by inflating a sphygmomanometer above systolic blood pressure for several minutes and watching for spasms of the hand, wrist, or fingers. TREATMENT OF HYDROFLUORIC ACID BURNS Remove contaminated clothing if the patient has not done so. If the burn occurred relatively recently, flush the area for 15 minutes with tepid water. If the BSA of the exposure is > 5%, or the concentration of the HF acid solution the patient was exposed to was > 50%, or the

patient s face was exposed, you can flush the exposed area even if the burn has occurred some time ago, but do not delay other treatment to do this. If the exposure is not considered serious, e.g., involvement of a low BSA, exposure to a low concentration of HF acid, and/or the patient is not having any signs or symptoms of hypocalcemia, there is no need for laboratory studies or an ECG. If the patient is having a lot of pain, consider obtaining an x-ray of the burned area. Proceed to treatment. If the exposure is considered serious, obtain IV access, place the patient on a cardiac monitor, get a x-ray of the burned area if that would be appropriate, obtain a 12-lead ECG, and obtain serum levels of calcium, magnesium, and potassium. Systemic and Local Treatment of a Hydrofluoric Acid Burn If the patient has hypocalcemia or hyperkalemia, give 10% calcium gluconate, 0.2-0.4 ml/kg IV, or 10% calcium chloride, 0.1-0.2 ml/kg, IV. Replace magnesium as needed Many HF acid burns involve small areas of the body, fingertips, etc. These patients can initially be treated with analgesics such as morphine or dilaudid. These medications will help to relive the pain, but they will not interrupt the pathological process that is causing the pain and they will not prevent further tissue damage. The most effective way to treat pain and prevent tissue damage is to use topical or parenteral calcium preparations. Calcium binds fluoride ions, alleviates pain, and prevents tissue damage. Learning Break: Do not use parenteral calcium chloride to treat HF acid burns. It is very irritating Topical calcium: There are commercially produced topical calcium gels that are intended for treating HF acid burns, but these preparations can easily be made by a pharmacy. To make a calcium preparation, dissolve 10% calcium gluconate solution in a sterile, water-soluble lubricant (e.g., K-Y Jelly ) at a 1:3 ratio or mix 3.5 grams of calcium gluconate powder in 5 ounces of sterile, water-soluble lubricant. Massage the calcium preparation into the affected area and then cover the area so that body heat can facilitate dermal absorption. If the pain is not relieved or significantly diminished within 30 minutes, the patient should be treated with parenteral calcium. Parenteral calcium: If the burn is moderate or severe, it is unlikely that topical calcium will be effective and the patient

should be given parenteral calcium, intradermally or intraarterially. Intradermal: Use a 27 or 30 gauge needle and inject 10% calcium gluconate, 0.5 ml into each cm 2 of the affected area. This technique can be used for extremities and digits. However, it can actually cause pain, increase tissue pressure in the area (potentially harmful in and of itself) and it must be used cautiously and with no more than 0.5 ml per digit. Intraarterial: This is reserved for serious or potentially serious cases. Use 10 ml of 10% calcium gluconate, mix with 50 ml of 5% dextrose and infuse over 4 hours through the radial or brachial artery. Repeat if needed. Learning Break: You may read in the medical literature of other ways of using calcium gel and parenteral calcium that differ from theses approaches. The protocols described here are derived from standard clinical toxicology texts, but at this time there is no standard, universally accepted protocol for using topical calcium gel and/or parenteral calcium to treat HF acid burns, the different possible approaches have not been directly compared, and none has been shown to be superior to the others. Researchers have also used milk, antacid liquids, cationic detergents, and other substances to treat HF acid burns, but these are not as effective and/or have side effects. OCULAR EXPOSURE TO HF ACID An ocular exposure to HF acid can be devastating. A Morgan lens should be placed and the eye should be irrigated with normal saline until an ophthalmologist has been consulted. Do not insert the Morgan lens, remove it, reinsert it, etc: this can cause. It is not clear whether using calcium in the eye will help or be harmful. Do not use calcium to irrigate the eye unless directed to do so by a physician or an ophthalmologist.